Literature DB >> 713130

Bacteriological investigation on biopsy specimens from patients with sarcoidosis.

J Y Homma, C Abe, H Chosa, K Ueda, J Saegusa, M Nakayama, H Homma, M Washizaki, H Okano.   

Abstract

Biopsy specimens, mostly lymph nodes, removed under aseptic conditions, were emulsified and the homogenate was inoculated in various media, which were incubated aerobically or anaerobically. Only Propionibacterium acnes was isolated in high incidence and the highest concentration of bacteria was 6.5 X 10(5) per g tissue: 28 and 31 out of 40 lymph nodes were positive on solid and on liquid media, respectively. P.acnes was also isolated from control non-sarcoidosis lymph nodes: 4 and 8 out of 14 were positive on solid and on liquid media, respectively. The highest concentration of bacteria was 1 X 10(4). A bacterial component derived from P. acnes was used for the passive hemagglutination test to estimate antibodies against the bacterium and also for skin test on patients. These results showed only slight differences between patients with sarcoidosis and control patients. No other bacteria or fungi were isolated.

Entities:  

Mesh:

Year:  1978        PMID: 713130

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


  19 in total

Review 1.  Skin microbiota: a source of disease or defence?

Authors:  A L Cogen; V Nizet; R L Gallo
Journal:  Br J Dermatol       Date:  2008-03       Impact factor: 9.302

2.  Pulmonary immune responses to Propionibacterium acnes in C57BL/6 and BALB/c mice.

Authors:  Joshua G McCaskill; Kelly D Chason; Xiaoyang Hua; Isabel P Neuringer; Andrew J Ghio; William K Funkhouser; Stephen L Tilley
Journal:  Am J Respir Cell Mol Biol       Date:  2006-04-27       Impact factor: 6.914

Review 3.  Etiologies of Sarcoidosis.

Authors:  Edward S Chen; David R Moller
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

4.  Localization of propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium.

Authors:  Mariko Negi; Tamiko Takemura; Josune Guzman; Keisuke Uchida; Asuka Furukawa; Yoshimi Suzuki; Tadatsune Iida; Ikuo Ishige; Junko Minami; Tetsuo Yamada; Hiroshi Kawachi; Ulrich Costabel; Yoshinobu Eishi
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

Review 5.  Etiology of sarcoidosis: does infection play a role?

Authors:  Shiv Saidha; Elias S Sotirchos; Christopher Eckstein
Journal:  Yale J Biol Med       Date:  2012-03-29

6.  TLR9-dependent and independent pathways drive activation of the immune system by Propionibacterium acnes.

Authors:  Sandrine Tchaptchet; Marina Gumenscheimer; Christoph Kalis; Nikolaus Freudenberg; Christoph Hölscher; Carsten J Kirschning; Marinus Lamers; Chris Galanos; Marina A Freudenberg
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

7.  Immune response to Propionibacterium acnes in patients with sarcoidosis--in vivo and in vitro.

Authors:  Jonas Christian Schupp; Sandrine Tchaptchet; Niklas Lützen; Peggy Engelhard; Joachim Müller-Quernheim; Marina A Freudenberg; Antje Prasse
Journal:  BMC Pulm Med       Date:  2015-07-24       Impact factor: 3.317

8.  Genetic profiles of Propionibacterium acnes and identification of a unique transposon with novel insertion sequences in sarcoid and non-sarcoid isolates.

Authors:  Kana Minegishi; Takayasu Watanabe; Asuka Furukawa; Keisuke Uchida; Yoshimi Suzuki; Takumi Akashi; Fumito Maruyama; Ichiro Nakagawa; Yoshinobu Eishi
Journal:  Sci Rep       Date:  2015-05-12       Impact factor: 4.379

9.  Complete Genome Sequence of a Propionibacterium acnes Isolate from a Sarcoidosis Patient.

Authors:  Kana Minegishi; Chihiro Aikawa; Asuka Furukawa; Takayasu Watanabe; Tsubasa Nakano; Yoshitoshi Ogura; Yoshiyuki Ohtsubo; Ken Kurokawa; Tetsuya Hayashi; Fumito Maruyama; Ichiro Nakagawa; Yoshinobu Eishi
Journal:  Genome Announc       Date:  2013-01-15

10.  Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes.

Authors:  Yoshinobu Eishi
Journal:  Biomed Res Int       Date:  2013-06-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.